Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2017

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Presenter: Nirat Beohar

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

Presenter: James B. Hermiller Jr.

November 01, 2017

Presentation TCT 2017

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

November 01, 2017

Presentation TCT 2017

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Presenter: Brij Maini

November 01, 2017

Presentation TCT 2017

Frequency of MR and Clinical Management Issues in TAVR Patients

Presenter: Marco Barbanti

November 01, 2017

Presentation TCT 2017

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Presenter: Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Presenter: Didier Tchetche

November 01, 2017

Presentation TCT 2017

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Presenter: Raj Makkar

November 01, 2017

Presentation TCT 2017

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Presenter: Hasan Jilaihawi

November 01, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Todd Neale

January 06, 2017

Advertisement

TAVR in Patients With Severe CKD: Diagnostic Workup, Valve Sizing, and Procedural and Post-Procedure Management

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

TAVR in AS Patients With Acute Coronary Syndromes, Left Main Disease, and Coronary Access After TAVR: Case Examples and Procedural Techniques

TAVR in AS Patients With Stable Coronary Disease: Evolving Treatment Issues (When to Consider CABG, Timing of PCI, and Completeness of Revascularization)

The Role of MitraClip Therapy in TAVR Patients - Treatment Paradigms (Who, When, and How) and Case Examples

Frequency of MR and Clinical Management Issues in TAVR Patients

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content